All In Biotech

Drug Trial Radar · NCT06953986

A Randomized, Three-Arm Study Comparing Vonaprazan 10 mg, Vonaprazan 20 mg, and Esomeprazole 40 mg for the Healing of LA Grade B or Higher Reflux Esophagitis at 8 Weeks

Study Comparing Vonaprazan 10 mg, Vonaprazan 20 mg, and Esomeprazole 40 mg for the Healing of LA Grade B or Higher Reflux Esophagitis at 8 Weeks

Last checked: Nov 20, 2026Latest source record: Mar 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 414 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

414

Planned (sponsor's estimate)

Start

Dec 20, 2025

Primary completion

Nov 20, 2026

Study completion Dec 12, 2027

Sponsor

Lead sponsor
Asian Institute of Gastroenterology, IndiaAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
May 1, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Factorial
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Primary Objective • To compare the healing rates of LA grade B or higher reflux esophagitis at 8 weeks among patients treated with Vonaprazan 10 mg, Vonaprazan 20 mg, and Esomeprazole 40 mg once daily. Secondary Objectives * To assess the improvement in reflux symptoms using the GERD-Q score at 8 weeks. * To evaluate the incidence of adverse events across treatment groups.

Conditions

  • GERD

Interventions

  • VonoprazanDrug

    Vonaprazon is potassium competitive acid blockers

  • Esomeprazole 40mgDrug

    esomeprazole is a proton pump inhibitor as it prevents excess of gastric acid secretion in the stomach

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. • Endoscopic healing of reflux esophagitis at 8 weeks (defined as resolution of LA grade B, C, or D esophagitis).Time frame: 8 weeks
  2. Endoscopic healing of reflux esophagitis at 8 weeks (defined as resolution of LA grade B, C, or D esophagitis).Time frame: 8 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Asian Institute of Gastroenterology /Aig Hospitals

    Hyderabad, Telangana, India · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.